![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1873-5592|14|12|1379-1384
ISSN: 1389-4501
Source: Current Drug Targets, Vol.14, Iss.12, 2013-11, pp. : 1379-1384
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Anti-IL-13 in Inflammatory Bowel Disease: From the Bench to the Bedside
Current Drug Targets, Vol. 14, Iss. 12, 2013-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Current Drug Targets. Inflammation & Allergy, Vol. 2, Iss. 2, 2003-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Botulinum Toxin a in Prostate Disease: A Venom from Bench to Bed-Side
Current Drug Delivery, Vol. 9, Iss. 1, 2012-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Vascular NO: from bench to bedside
European Journal of Clinical Pharmacology, Vol. 62, Iss. 1, 2006-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
CETUXIMAB: From Bench to Bedside
Current Cancer Drug Targets, Vol. 10, Iss. 1, 2010-01 ,pp. :